Hold MDLZ with conditional add-on architecture on 200 SMA test and mandatory alpha-loss trim trigger
Discipline test with executable tactical refinement. The structural 200 SMA floor at $58.85 is intact, the 3.39% dividend provides real carry, and the Neutral analyst's conditional add-on architecture captures 200 SMA test optionality without underwriting unconfirmed catalysts. The aggressive analyst's wider-stop mandate and conservative analyst's rigidity are both rejected. Mandatory alpha-loss trim trigger (-1.5% vs SPY over 10 sessions) addresses silent alpha bleed from passive Holds. HOLD with tight execution parameters is the highest expected-value path through the Q3 2026 catalyst window.
| Position | Action |
|---|---|
| Price trades into $58.50-$59.00 zone with daily close >$59.00 within 3 sessions, RSI higher low, MACD histogram compressing toward zero, and bounce-session volume >7M | Add tactical tranche at 25-30% of existing position with stop at $58.00 |
| MDLZ underperforms SPY by -1.5% over 10 sessions while structural floor holds intact | Trim ~15% of remaining position into strength (mandatory, not discretionary) |
| Close <$58.50 on volume ≥10M (hard downgrade trigger) | Trim residual aggressively toward 25-30% of target weight |
MDLZ represents a buyable pullback within a long-term uptrend, with trough earnings already reported, cocoa input costs normalizing, deleveraging underway, and the stock trading at a discount to its historical multiple—all while offering a 3.39% dividend yield and asymmetric upside to $66.65.
| Indicator | Value | Signal |
|---|---|---|
| 200 SMA | 58.85 | bullish |
| 50 SMA | 62.07 | bearish |
| 10 EMA | 61.47 | bearish |
| 20 SMA (Bollinger Middle) | 61.89 | bearish |
| Bollinger Upper Band | 63.31 | neutral |
| Bollinger Lower Band | 60.47 | neutral |
| RSI (14) | 43.11 | neutral |
| MACD | -0.33 | bearish |
| MACD Signal | -0.15 | bearish |
| MACD Histogram | -0.18 | bearish |
| ATR (14) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close >$62.50 on volume ≥10M with MACD histogram positive
Then: Upgrade to Overweight
Cocoa cost cycle has already troughed; margin recovery is the next leg
↩ rebuts: “Bear pricing MDLZ on trough earnings”
EV: +9.5% to 52-week highs at $66.65 · concedes: Bear correctly identified the 200 SMA at $58.85 as key support level; Bear correctly flagged declining volume on 9/24 (5.72M); Bear correctly identified MACD cross below zero on 9/17; Bear correctly cited macro headwinds: 10Y at 2007 highs, 30Y at 2004 highs, strong USD; Bear correctly noted 2025 capital returns ($4.87B) exceeded FCF ($3.24B) — though this was the trough year; Bear correctly identified 40%+ EM revenue exposure to strong USD headwind — though this is a two-way risk if Fed pivots
MDLZ is not a buy at current levels — the technicals are broken with a confirmed lower-high/lower-low sequence, the fundamentals show trough margins that may not recover if cocoa lingers at elevated levels, and the macro backdrop of 10Y at 2007 highs, a Fed pricing hikes not cuts, and strengthening USD creates a hostile environment with no near-term catalyst to drive the stock back to $64.70.
· concedes: 9/24 close at $60.86 did hold above $60.17 intraday low from 9/21 — a retest of the 9/21 low did not break below it immediately; MDLZ is 3.4% above the 200 SMA at $58.85 — technically still above the last line of defense; The 200 SMA is the last line of defense — if it holds with a reversal candle, the risk/reward improves; A reclaim of $62.50 on expanding volume would offer a better entry — waiting for confirmation is prudent; EM currencies will eventually rebound — the strong USD headwind is cyclical, not permanent; GLP-1 threat may be overstated in the near term — structural risk is multi-year, not immediate; Dividend at 3.39% does provide some income support if held (though coverage is declining)
→ vs conservative: 17.7M volume day is being treated as regime change when tape shows selling exhaustion; 5.7M volume yesterday below average confirms no continued institutional dumping
→ vs neutral: MACD is lagging indicator being overweighted relative to price location at lower Bollinger band; also treating absence of catalyst as reason to wait when catalyst window (Q3 print, cocoa normalization, defensive rotation) is opening now
→ vs conservative: 10-year at 2007 highs and hawkish Fed is actually bullish for consumer staples/defensives like MDLZ; waiting to buy a 0.40 beta name until macro clears means buying after it has already rallied 8-10%
| 1.28 |
| neutral |
| Close | 60.86 | neutral |
| Volume | 5723780 | neutral |
Support: 60.47 · 60.17 · 58.85 · 58 | Resistance: 61.47 · 61.89 · 62.07 · 62.5 · 63.31 · 64.7
MDLZ exhibits a short-term bearish correction within a structurally intact long-term uptrend. Price has closed below the 10 EMA (61.47), 50 SMA (62.07), and Bollinger middle (61.89), but remains 3.4% above the rising 200 SMA at 58.85. Momentum is bearish with MACD at -0.33 and expanding negative histogram (-0.18), while RSI at 43.11 indicates neutral-to-weak conditions without oversold confirmation. The recent high-volume distribution on 9/18 (17.7M shares) followed by a low-volume failed bounce suggests continued downside risk toward the 200 SMA, though a reclaim above $62.50 on expanding volume would re-open bullish potential toward $64.70.
Market Cap
$77.68 B
Share Price (approx.)
~$60.88
52-Week High
$66.65
52-Week Low
$51.20
50-Day Average
$62.08
200-Day Average
$59.43
P/E (TTM)
22.3x
Forward P/E
18.1x
PEG Ratio
0.91
Price / Book
2.93x
Dividend Yield
3.39%
Beta
0.40
Revenue (2025)
$38,537 M
Revenue (2024)
$36,441 M
Revenue (2023)
$36,016 M
Revenue (2022)
$31,496 M
Gross Profit (2025)
$10,935 M
Gross Profit (2024)
$14,257 M
Operating Income (2025)
$3,548 M
Operating Income (2024)
$6,345 M
Net Income (2025)
$2,451 M
Net Income (2024)
$4,611 M
Diluted EPS (2025)
$1.89
Diluted EPS (2024)
$3.42
Diluted EPS (2023)
$3.62
Diluted EPS (2022)
$1.96
EBITDA (2025)
$4,971 M
EBITDA (2024)
$8,071 M
Total Assets (2025)
$71,487 M
Total Assets (2024)
$68,497 M
Total Equity (2025)
$25,838 M
Total Equity (2024)
$26,932 M
Total Debt (2025)
$21,804 M
Total Debt (2024)
$18,372 M
Net Debt (2025)
$19,080 M
Net Debt (2024)
$16,398 M
Cash & Equivalents (2025)
$2,125 M
Cash & Equivalents (2024)
$1,351 M
Inventory (2025)
$4,419 M
Inventory (2024)
$3,827 M
Goodwill & Intangibles (2025)
$43,964 M
Goodwill & Intangibles (2024)
$41,865 M
Current Ratio
0.60
Working Capital (2025)
($8,913) M
Tangible Book Value
($18.1B)
Operating Cash Flow (2025)
$4,514 M
Operating Cash Flow (2024)
$4,910 M
Capital Expenditures (2025)
($1,279) M
Capital Expenditures (2024)
($1,387) M
Free Cash Flow (2025)
$3,235 M
Free Cash Flow (2024)
$3,523 M
FCF per Share
$2.49
FCF Yield
~4.1%
Dividends Paid (2025)
($2,487) M
Dividends Paid (2024)
($2,349) M
Share Repurchases (2025)
($2,385) M
Share Repurchases (2024)
($2,334) M
Total Capital Return (2025)
$4.87B
Annual Dividend
~$2.00/share
Net Debt / EBITDA
~3.8x
Operating Margin (TTM)
21.98%
Net Profit Margin (2025)
8.86%
EBITDA Margin (TTM)
~15.3%
Gross Margin (TTM)
31.1%
ROE
13.34%
ROA
4.12%
Q1'26 Revenue
$10,080 M
Q1'26 Operating Income
$808 M
Q1'26 Net Income
$560 M
Q1'26 EPS
$0.44
Q2'26 EPS
$1.20
Forward EPS Estimate
$3.36
Revenue Q1'26 YoY Growth
+8.2%
Revenue 2025 YoY Growth
+5.7%
Revenue 2024 YoY Growth
+1.2%
5-Year Revenue CAGR
~5.9%
Strengths
Concerns
MDLZ is a high-quality defensive franchise with world-class brands (Oreo, Cadbury, Milka, Toblerone) that delivered a dramatic 2025 earnings reset — net income halved to $2.45B due to cocoa and input cost inflation — while FCF proved far more resilient, falling only 8% to $3.24B. The stock trades at a reasonable forward P/E of 18.1x with a 0.91 PEG ratio and 4.1% FCF yield, supported by a 3.39% dividend, though elevated net debt of $19.1B (3.8x EBITDA) and capital returns exceeding FCF by $1.7B create balance-sheet risk. Q1'26 revenue reacceleration (+8.2% YoY) and active deleveraging signal management is restoring the business, but cocoa price volatility, negative tangible book value, and the $2.6B commercial paper load warrant monitoring for risk-oriented portfolios.
Macro: Hawkish bond repricing dominates: 10-year Treasury yield at highest level since 2007; 30-year at highest since 2004. Futures markets pricing another Fed rate hike rather than earlier-expected cuts, with Polymarket showing 97% implied probability of zero rate cuts in 2026 (up 1.6pp week-over-week). US recession odds at 10% (+1.0pp w/w), supporting soft-landing base case. USD strengthening on rate differentials and haven flows; oil near $100 with Iran war uncertainty. Jamie Dimon notes inflation is not clearly 'slayed.'